GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TearLab Corp (OTCPK:TEAR) » Definitions » Shiller PE Ratio

TearLab (TearLab) Shiller PE Ratio : (As of May. 05, 2024)


View and export this data going back to 2004. Start your Free Trial

What is TearLab Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


TearLab Shiller PE Ratio Historical Data

The historical data trend for TearLab's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TearLab Shiller PE Ratio Chart

TearLab Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TearLab Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TearLab's Shiller PE Ratio

For the Diagnostics & Research subindustry, TearLab's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TearLab's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TearLab's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TearLab's Shiller PE Ratio falls into.



TearLab Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TearLab's E10 for the quarter that ended in Mar. 2020 is calculated as:

For example, TearLab's adjusted earnings per share data for the three months ended in Mar. 2020 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2020 (Change)*Current CPI (Mar. 2020)
=-0.12/108.9015*108.9015
=-0.120

Current CPI (Mar. 2020) = 108.9015.

TearLab Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201006 -1.000 91.962 -1.184
201009 -1.500 92.162 -1.772
201012 -0.500 92.474 -0.589
201103 -1.100 94.283 -1.271
201106 -3.100 95.235 -3.545
201109 0.500 95.727 0.569
201112 -1.800 95.213 -2.059
201203 -4.400 96.783 -4.951
201206 -1.000 96.819 -1.125
201209 -1.700 97.633 -1.896
201212 -1.200 96.871 -1.349
201303 -3.000 98.209 -3.327
201306 -4.100 98.518 -4.532
201309 -1.300 98.790 -1.433
201312 -1.100 98.326 -1.218
201403 -1.700 99.695 -1.857
201406 -1.700 100.560 -1.841
201409 -1.716 100.428 -1.861
201412 -2.100 99.070 -2.308
201503 -2.500 99.621 -2.733
201506 -2.400 100.684 -2.596
201509 -2.400 100.392 -2.603
201512 -2.600 99.792 -2.837
201603 -2.140 100.470 -2.320
201606 -0.970 101.688 -1.039
201609 -0.750 101.861 -0.802
201612 -0.810 101.863 -0.866
201703 -0.824 102.862 -0.872
201706 -0.680 103.349 -0.717
201709 -0.670 104.136 -0.701
201712 -0.630 104.011 -0.660
201803 -0.092 105.290 -0.095
201806 -0.060 106.317 -0.061
201809 -0.020 106.507 -0.020
201812 -0.040 105.998 -0.041
201903 -0.120 107.251 -0.122
201906 -0.100 108.070 -0.101
201909 -0.140 108.329 -0.141
201912 -0.090 108.420 -0.090
202003 -0.120 108.902 -0.120

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TearLab  (OTCPK:TEAR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


TearLab Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of TearLab's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TearLab (TearLab) Business Description

Traded in Other Exchanges
N/A
Address
150 LaTerraza Boulevard, Suite 101, Escondido, CA, USA, 92025
TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned subsidiary, TearLab Research Inc. Most of the company's revenue is derived from the United States region.
Executives
Anthony E Altig director C/O OPTIMER PHARMACEUTICALS, INC, 101 HUDSON STREET, JERSEY CITY NJ 07302
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Lindstrom Richard L Md director 2811 WESTWOOD PL, WAYZATA MN 55391
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Adrienne L Graves director 125 STONE MOUNTAIN CIRCLE, NAPA CA 94558
Gilbert S Omenn director AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
John Y Caloz officer: Chief Financial Officer ETON AVE, C/O INTERNATIONAL REMOTE IMAGING SYS, CHATSWORTH CA 91311